GENES

Normal Expression

Altered Expression

P Value

GENES

Normal Expression

Altered Expression

P Value

BRCA1 ER/PR+ ER/PR-

8(100%) 11(100%)

0(0%) 0(10%)

0.882

BRCA1 ER/PR+ ER/PR-

7(87.5%) 10(90%)

1(12.5%) 1(10%)

0.811

BRCA2 ER/PR+ ER/PR-

8(100%) 11(100%)

0(0%) 8(0%)

0.096

BRCA2 ER/PR+ ER/PR-

5(62.5%) 9(81.8%)

3(37.5%) 2(18.1%)

0.353

HER2 ER/PR+ ER/PR-

5(62.5%) 6(54.54%)

3(37.5%) 5(45.45%)

0.729

HER2 ER/PR+ ER/PR-

1(12.5%) 4(36.3%)

7(87.5%) 7(63.63%)

0.263

ER ER/PR+ ER/PR-

8(100%) 10(90%)

0(0%) 1(10%)

0.601

ER ER/PR+ ER/PR-

0(0%) 10(90%)

8(100%) 1(10%)

0.004

PR ER/PR+ ER/PR-

6(75%) 10(90%)

2(25%) 1(10%)

0.365

PR ER/PR+ ER/PR-

0(0%) 10(90%)

8(100%) 1(10%)

0.004

PI3KCA ER/PR+ ER/PR-

5(62.5%) 9(81.8%)

3(37.5%) 2(18.1%)

0.353

PI3KCA ER/PR+ ER/PR-

5(62.5%) 5(45.4%)

3(37.5%) 6(54.5%)

0.465

EGFR ER/PR+ ER/PR-

5(62.5%) 6(54.5%)

3(37.5%) 5(45.4%)

0.729

EGFR ER/PR+ ER/PR-

3(37.5%) 5(45.4%)

5(62.5%) 6(54.5%)

0.465

MET ER/PR+ ER/PR-

7(87.5%) 8(72.7%)

1(12.5%) 3(27.2%)

0.445

MET ER/PR+ ER/PR-

2(25%) 7(63.6%)

6(75%) 4(36.3%)

0.107

PTEN ER/PR+ ER/PR-

1(12.5%) 4(36.36%)

7(87.5%) 7(63.3%)

0.263

PTEN ER/PR+ ER/PR-

7(87.5%) 6(54.5%)

1(12.5%) 5(45.4%)

0.151

BRAF ER/PR+ ER/PR-

8(100%) 11(100%)

0(0%) 0(0%)

0.882

BRAF ER/PR+ ER/PR-

5(62.5%) 9(81.8%)

3(37.5%) 2(16.6%)

0.353

Table 6: Correlation between multi gene expressions with ER and PR status.